Hakutulokset - Llombart-Cussac, Antonio

Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects Tekijä Gion, María, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Sampayo-Cordero, Miguel, Cortés, Javier, Malfettone, Andrea

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 Tekijä Di Cosimo, Serena, Malfettone, Andrea, Pérez-García, José M., Llombart-Cussac, Antonio, Miceli, Rosalba, Curigliano, Giuseppe, Cortés, Javier

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality Tekijä Andreu-Ballester, Juan Carlos, Pons-Castillo, Aurelio, González-Sánchez, Antonio, Llombart-Cussac, Antonio, Cano, María José, Cuéllar, Carmen

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy Tekijä Honrubia-Peris, Beatriz, Garde-Noguera, Javier, García-Sánchez, Jose, Piera-Molons, Nuria, Llombart-Cussac, Antonio, Fernández-Murga, María Leonor

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, wit... Tekijä Garde Noguera, Javier, Jantus-Lewintre, Eloisa, Gil-Raga, Mireia, Evgenyeva, Elena, Maciá Escalante, Sonia, Llombart-Cussac, Antonio, Camps Herrero, Carlos

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The role of CDK4/6 inhibitors in early breast cancer Tekijä Gil-Gil, Miguel, Alba, Emilio, Gavilá, Joaquín, de la Haba-Rodríguez, Juan, Ciruelos, Eva, Tolosa, Pablo, Candini, Daniele, Llombart-Cussac, Antonio

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II) Tekijä Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier, Pardo, Almudena, Pérez-López, Jordi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Thera... Tekijä Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier, Pardo, Almudena, Pérez-López, Jordi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Nobody dares stopping clinical research, not even COVID-19 Tekijä Malfettone, Andrea, Di Cosimo, Serena, Pérez-García, José Manuel, García, Alicia, Sampayo-Cordero, Miguel, Mina, Leonardo, Herrero, Carolina, Llombart-Cussac, Antonio, Cortés, Javier

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy Tekijä Di Leo, Angelo, O’Shaughnessy, Joyce, Sledge, George W., Martin, Miguel, Lin, Yong, Frenzel, Martin, Hardebeck, Molly C., Smith, Ian C., Llombart-Cussac, Antonio, Goetz, Matthew P., Johnston, Stephen

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Progress Against Solid Tumors in Danger: The Metastatic Breast Cancer Example Tekijä Cortés, Javier, Calvo, Emiliano, González-Martín, Antonio, Dawood, Shaheenah, Llombart-Cussac, Antonio, De Mattos-Arruda, Leticia, Gómez, Patricia, Silva, Orlando, Perez, Edith A., Rugo, Hope S., Lluch, Ana, Hortobagyi, Gabriel N.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population Tekijä Garde-Noguera, Javier, Fernández-Murga, M. Leonor, Giner-Bosch, Vicent, Dominguez-Márquez, Victoria, Sánchez, José García, Soler-Cataluña, Juan José, López Chuliá, Franscica, Honrubia, Beatriz, Piera, Nuria, Llombart-Cussac, Antonio

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type... Tekijä Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pardo-Mateos, Almudena, Malfettone, Andrea, Pérez-García, José, Llombart-Cussac, Antonio, Cortés, Javier, Moltó-Abad, Marc, Muñoz-Delgado, Cecilia, Pérez-Quintana, Marta, Pérez-López, Jordi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors Tekijä Andreu-Ballester, Juan Carlos, Galindo-Regal, Lorena, Hidalgo-Coloma, Julia, Cuéllar, Carmen, García-Ballesteros, Carlos, Hurtado, Carolina, Uribe, Natalia, del Carmen Martín, María, Jiménez, Ana Isabel, López-Chuliá, Francisca, Llombart-Cussac, Antonio

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design Tekijä Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pérez-García, José, Páez, David, Guerrero-Zotano, Ángel L., Garde-Noguera, Javier, Aguirre, Elena, Holgado, Esther, López-Miranda, Elena, Huang, Xin, Malfettone, Andrea, Llombart-Cussac, Antonio, Cortés, Javier

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-neg... Tekijä Inoue, Kenichi, Masuda, Norikazu, Iwata, Hiroji, Takahashi, Masato, Ito, Yoshinori, Miyoshi, Yasuo, Nakayama, Takahiro, Mukai, Hirofumi, van der Walt, Jan-Stefan, Mori, Joji, Sakaguchi, Sachi, Kawaguchi, Tsutomu, Tanizawa, Yoshinori, Llombart-Cussac, Antonio, Sledge, George W., Toi, Masakazu

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial Tekijä López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole Tekijä Garcia-Casado, Zaida, Guerrero-Zotano, Angel, Llombart-Cussac, Antonio, Calatrava, Ana, Fernandez-Serra, Antonio, Ruiz-Simon, Amparo, Gavila, Joaquin, Climent, Miguel A, Almenar, Sergio, Cervera-Deval, Jose, Campos, Josefina, Albaladejo, Carlos Vazquez, Llombart-Bosch, Antonio, Guillem, Vicente, Lopez-Guerrero, Jose A

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2: A Randomiz... Tekijä Sledge, George W., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Inoue, Kenichi, Pivot, Xavier, Burdaeva, Olga, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A., Koh, Han, Grischke, Eva-Maria, Conte, PierFranco, Lu, Yi, Barriga, Susana, Hurt, Karla, Frenzel, Martin, Johnston, Stephen, Llombart-Cussac, Antonio

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial Tekijä Pascual, Tomás, Oliveira, Mafalda, Villagrasa, Patricia, Ortega, Vanesa, Paré, Laia, Bermejo, Begoña, Morales, Serafín, Amillano, Kepa, López, Rafael, Galván, Patricia, Canes, Jordi, Salvador, Fernando, Nuciforo, Paolo, Rubio, Isabel T., Llombart-Cussac, Antonio, Di Cosimo, Serena, Baselga, José, Harbeck, Nadia, Prat, Aleix, Cortés, Javier

Hae kokoteksti Hae kokoteksti Hae kokoteksti